Peripheral endothelial dysfunction is a novel risk factor for systolic dysfunction and heart failure progression

BACKGROUND: ACC/AHA guidelines recognize the progressive nature of heart failure (HF). Patients with risk factors (Stage A) are at risk for developing asymptomatic cardiac dysfunction (Stage B), which may then lead to symptomatic HF (Stage C). As such, therapies targeting abnormalities in stages A a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Cardiol Heart Vasc
Hlavní autoři: Taher, Riad, Sara, Jaskanwal D., Toya, Takumi, Borlaug, Barry A., Lerman, Lilach O., Lerman, Amir
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7385446/
https://ncbi.nlm.nih.gov/pubmed/32743042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100584
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky